Monday, April 20, 2015

Bristol-Myers immunotherapy combo promising in melanoma-study - Reuters


Wall Street Journal

Bristol-Myers immunotherapy combo promising in melanoma-study
Reuters
April 20 (Reuters) - A combination of two Bristol-Myers Squibb drugs that help the immune system fight melanoma led to significantly greater tumor shrinkage than treatment with one of the medicines, according to a midstage study presented on Monday.
Bristol-Myers: 2 cancer drugs beat 1 against melanomaSan Francisco Chronicle
Bristol-Myers Drug Combination Shows Promise Against MelanomaWall Street Journal
First Randomized Study Evaluating Opdivo (nivolumab)+Yervoy (ipilimumab ...Digital Journal

all 4 news articles »

http://ift.tt/1D6lWuv
by via Health - Google News

No comments:

Post a Comment

Medicalia.org

Medicalia.org
developed by Internet Medical Society